DTL
ABCL icon

Dynamic Technology Lab’s AbCellera Biologics ABCL Stock Holding History

Dynamic Technology Lab’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,112
Closed -$86K – 969
2024
Q2 		$86K Buy
+29,112
New +$110K 0.01% 859
2023
Q1 		– Sell
-32,546
Closed -$329K – 1027
2022
Q4 		$329K Buy
32,546
+3,557
+12% +$41.1K 0.03% 737
2022
Q3 		$286K Buy
+28,989
New +$318K 0.03% 823
2022
Q2 		– Sell
-31,427
Closed -$306K – 1064
2022
Q1 		$306K Buy
+31,427
New +$298K 0.04% 779

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return